Assignee

Promentis Pharmaceuticals, Inc.

Patents = 9

Trademarks = 1

Forward Citations = 36

where 'Filed Patents' based on already Granted Patents

where 'Inventors Filed' based on already Granted Patents

8 inventors (with patents filed for the assignee):

Promentis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative therapies for neuropsychiatric and neurologic disorders. Their pipeline includes novel small molecule drugs targeting specific brain receptors to treat conditions such as schizophrenia, Tourette syndrome, and substance use disorders.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com